ABREOS BIOSCIENCES

Company Overview
Marketing Materials
Data Room
Management Bios
Videos
News & Articles
Contact Us
Company Overview
COMPANY OVERVIEW

 

Abreos is dedicated to improving the development and commercialization of biopharmaceuticals with our proprietary Veritope platform.

Abreos Biosciences is a privately owned, San Diego-based biotechnology company developing integrated pharmaceuticals for oncology, neurology and autoimmune disease. Our proprietary VeritopeTM platform is comprised of mimetope peptides that can bind to monoclonal antibodies and other biologic drugs.

Built upon research from the Moores Cancer Center at UC San Diego by Abreos Founder Bradley Messmer PhD, the VeritopeTM technology has been validated by six major pharma partners in applications to create:

– Faster and more robust clinical assays

– Improved purification methods

– Improved Clinical PK Studies

– Novel PK/PD approaches to monitor biologic drugs

Abreos Biosciences currently has one commercially available laboratory developed test and a leading therapeutic asset in neurological disease.

Deal Size
$125,000,000
Min Investment
$5,000,000
Industry
Hedge Funds
Type of Investment
1031 Exchange
Location
San Diego, CA
Contact Us

Marketing Materials
Data Room
DATA ROOM
No items found
Management Bios
MANAGEMENT BIOS
No items found
Videos
VIDEOS
No items found
News & Articles
NEWS & ARTICLES
No items found
Contact Us
CONTACT US
OFFICE ADDRESS:
3550 General Atomics Ct, San Diego, CA 92121, USA

P: 858 203 1168
E: [email protected]

LinkedIn Profile